- Home
- CAC vs VALN Comparison
CAC vs VALN Comparison
Compare CAC & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- VALN
- Stock Information
- Founded
- CAC 1875
- VALN 2012
- Country
- CAC United States
- VALN France
- Employees
- CAC N/A
- VALN N/A
- Industry
- CAC Major Banks
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CAC Finance
- VALN Health Care
- Exchange
- CAC Nasdaq
- VALN Nasdaq
- Market Cap
- CAC 680.5M
- VALN 777.9M
- IPO Year
- CAC 1997
- VALN 2021
- Fundamental
- Price
- CAC $38.60
- VALN $10.63
- Analyst Decision
- CAC Buy
- VALN Strong Buy
- Analyst Count
- CAC 3
- VALN 4
- Target Price
- CAC $48.00
- VALN $15.75
- AVG Volume (30 Days)
- CAC 66.9K
- VALN 78.2K
- Earning Date
- CAC 10-28-2025
- VALN 11-06-2025
- Dividend Yield
- CAC 4.35%
- VALN N/A
- EPS Growth
- CAC 4.80
- VALN N/A
- EPS
- CAC 3.11
- VALN N/A
- Revenue
- CAC $197,501,000.00
- VALN $230,566,060.00
- Revenue This Year
- CAC $42.11
- VALN $15.69
- Revenue Next Year
- CAC $5.51
- VALN $22.15
- P/E Ratio
- CAC $12.41
- VALN N/A
- Revenue Growth
- CAC 21.74
- VALN 25.47
- 52 Week Low
- CAC $34.53
- VALN $3.62
- 52 Week High
- CAC $50.07
- VALN $12.25
- Technical
- Relative Strength Index (RSI)
- CAC 43.84
- VALN 54.35
- Support Level
- CAC $37.50
- VALN $9.70
- Resistance Level
- CAC $39.84
- VALN $12.23
- Average True Range (ATR)
- CAC 0.96
- VALN 0.44
- MACD
- CAC -0.12
- VALN 0.05
- Stochastic Oscillator
- CAC 23.94
- VALN 36.76
About CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.